Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures

Life Sciences

Volumn 80, Issue 3, 2006, Pages 193-199

  Tian, Yuan Yuan ^a   An, Li Jia ^a   Jiang, Lan ^b   Duan, Yan Long ^a   Chen, Jun ^c   Jiang, Bo ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b NORTHEASTERN UNIVERSITY   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Catalpol; Inflammation; Lipopolysaccharide; Microglia; Neurodegeneration; Neurons

Indexed keywords

CATALPOL; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; GLIA CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MESENCEPHALON; MICROGLIA; MOUSE; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSIDES; INFLAMMATION; IRIDOIDS; LIPOPOLYSACCHARIDES; MESENCEPHALON; MICE; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

GERBILLINAE; REHMANNIA GLUTINOSA;

EID: 33845204785     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.09.010     Document Type: Article

References (30)

1. Arimoto T., and Bing G. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiology Disease 12 1 (2003) 35-45
2. Becher B., Fedorowicz V., and Antel J.P. Regulation of CD14 expression on human adult central nervous system-derived microglia. Journal of Neuroscience Research 45 (1996) 375-381
3. Dawson V.L., and Dawson T.M. Nitric oxide in neuronal degeneration. Proceedings of the Society for Experimental Biology and Medicine 211 (1996) 33-40
4. Dawson V.L., Brahmbhatt H.P., Mong J.A., and Dawson T.M. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology 33 (1994) 1425-1430
5. Farber J.L. Mechanisms of cell injury by activated oxygen species. Environmental Health Perspectives 102 (1994) 17-24
6. Gao H.M., Hong J.S., Zhang W.Q., and Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. Journal of Neuroscience 22 (2002) 782-790
7. Gao H.M., Hong J.S., Zhang W.Q., and Liu B. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. Journal of Neuroscience 23 (2003) 1228-1236
8. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical Biochemistry 126 (1982) 131-138
9. Hirsch E.C., Hunot S., Damier P., and Faucheux B. Glial cell and inflammation in Parkinson's disease: a role in neurodegeneration?. Annals of Neurology 44 (1998) S115-S120
10. Hunot S., Boiissiere F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., and Hirsch E.C. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72 (1996) 355-363
11. Iravani M.M., Kashefi K., Mander P., Rose S., and Jenner P. Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110 (2002) 49-58
12. Jiang B., Liu J.H., Bao Y.M., and An L.J. Catalpol inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade. Toxicon 43 (2004) 53-59
13. Kremlev S.G., Roberts R.L., and Palmer C. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. Journal of Neuroimmunology 149 (2004) 1-9
14. Kurkowska-Jastrzebska I., Wronska A., Kohutnicka M., Czlonkowski A., and Czlonkowska A. The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse. Experimental Neurology 156 1 (1999) 50-61
15. Le W., Rowe D., Xie W., Ortiz L., He Y., and Appel S.H. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. Journal of Neuroscience Methods 21 (2001) 8447-8455
16. Li D.Q., Duan Y.L., Bao Y.M., Liu C.P., Liu Y., and An L.J. Neuroprotection of catalpol in transient global ischemia in gerbils. Neuroscience Research 50 (2004) 169-177
17. Li Q., Liu Y., Wang T., Wei S.J., Block M.L., Wilson B., Liu B., and Hong J.S. NADPH oxidase mediates LPS-induced neurotoxicity and pro-inflammatory gene expression in activated microglia. Journal of Biological Chemistry 279 (2004) 1415-1421
18. Li D.Q., Li Y., Liu Y.X., Bao Y.M., Hu B., and An L.J. Catalpol prevents the loss of CA1 hippocampal neurons and reduces working errors in gerbils after ischemia-reperfusion injury. Toxicon 46 (2005) 845-851
19. Liu B., Du L., and Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. The Journal of Pharmacology and Experimental Therapeutics 293 (2000) 607-617
20. Liu B., Jiang J.W., Wilson B.C., Du L., Yang S.N., Wang J.Y., Wu G.C., Cao X.D., and Hong J.S. Systemic infusion of naloxone reduces degeneration of rat substantianigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. The Journal of Pharmacology and Experimental Therapeutics 295 (2000) 125-132
21. Liu B., Wang K., Gao H.M., Mandavilli B., Wang J.Y., and Hong J.S. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. Journal of Neurochemistry 77 (2001) 182-189
22. Liu B., Gao H.M., Wang J.Y., Jeohn G.H., Cooper C.L., and Hong J.S. Role of nitric oxide in inflammation-mediated neurodegeneration. Annals of the New York Academy of Sciences 962 (2002) 318-331
23. Mosmann T. Rapid colorimetric assay for cellular growth and survivals: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65 (1983) 55-63
24. Olanow C.W., and Tawwon W.G. Etiology and pathogenesis of Parkinson's disease. Annual Review of Neuroscience 22 (1999) 123-144
25. Orr C.F., Rowe D.B., and Halliday G.M. An inflammatory review of Parkinson's disease. Progress in Neurobiology 68 (2002) 325-340
26. Peng G.S., Li G.R., Tzeng N.S., Chen P.S., Chuang D.M., Hsu Y.D., Yang S.F., and Hong J.S. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. Molecular Brain Research 134 (2005) 162-169
27. Rosenberger J., Petrovics G., and Buzas B. Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38-and ERK-MAP kinases and NF-kappaB. Journal of Neurochemistry 79 (2001) 35-44
28. Wang A.L., Yu A.C., Lau L.T., Lee C., Wu L.M., Zhu X., and Tso M.O. Minocycline inhibits LPS-induced retinal microglia activation. Neurochemistry International 47 (2005) 152-158
29. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., and Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. Journal of Neuroscience 22 (2002) 1763-1771
30. Zhou H.F., Liu X.Y., Niu D.B., Li F.Q., He Q.H., and Wang X.M. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiology of Disease 18 (2005) 441-449